Dr. Tali Fishman-Jacob is the Director of Preclinical Research for Remedy Cell.

She has managed preclinical and clinical development of novel diabetes Rx, executed preclinical programs in next-generation glaucoma treatments, and has extensive experience in performing in-vivo and in-vitro efficacy and toxicity studies.